A multivariate approach for assessing severity of acute graft-versus-host disease in bone marrow transplantation

被引:0
|
作者
Parrish, RS
Hazlett', LJ
Bridges, KD
Henslee-Downey, PJ
机构
[1] Ctr Canc, Div Biometry & Res Comp, Columbia, SC 29203 USA
[2] Univ S Carolina, Sch Med, Dept Med, Ctr Canc Treatment & Res,Palmetto Richland Mem Ho, Columbia, SC 29208 USA
[3] Univ S Carolina, Sch Med, Ctr Canc Treatment & Res, Dept Pediat,Palmetto Richland mem Hosp, Columbia, SC USA
[4] Univ S Carolina, Sch Med, Palmetto Richland Mem Hosp, Div Transplantat Med,Ctr Canc Treatment & Res, Columbia, SC USA
关键词
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Patients undergoing bone marrow transplantation are at high risk of developing acute graft-versus-host disease (GVHD) which is a primary limiting factor for this procedure inasmuch as it is responsible for high morbidity rates and is associated with poor survival outcome. To provide improved treatment assessment and better interpretation of clinical outcomes, we need a precise and objective assessment of GVHD, Severity of GVHD is commonly assessed using an imprecise categorical grading system that incorporates skin, gut and liver grades, as well as subjective assessment of clinical performance. These organ grades are based on arbitrary cutpoints of skin rash, diarrhoea volume and bilirubin level. The International Bone Marrow Transplant Registry proposed an alternative grading system based on different combinations of organ involvement and provided estimates of relative risk of treatment failure. On the basis of that work, we developed an empirical mathematical model that quantifies GVHD severity, and that uses continuous, rather than categorical, daily measurements for each organ system. We use model-predicted values as an index of severity for any combination of values. The proposed index allows a more precise comparison of GVHD profiles across different treatment protocols and also permits more refined analyses to address relationships between GVHD and clinical outcomes. Copyright (C) 1999 John Wiley & Sons, Ltd.
引用
收藏
页码:423 / 440
页数:18
相关论文
共 50 条
  • [31] Serum TNFα levels in patients with acute graft-versus-host disease after bone marrow transplantation
    XJ Huang
    J Wan
    DP Lu
    Leukemia, 2001, 15 : 1089 - 1091
  • [32] PROPHYLAXIS FOR ACUTE GRAFT-VERSUS-HOST DISEASE FOLLOWING UNRELATED DONOR BONE-MARROW TRANSPLANTATION
    PHILLIPS, GL
    NEVILL, TJ
    SPINELLI, JJ
    NANTEL, SH
    KLINGEMANN, HG
    BARNETT, MJ
    SHEPHERD, JD
    CHAN, KW
    MEHARCHAND, JM
    SUTHERLAND, HJ
    REECE, DE
    MESSNER, HA
    BONE MARROW TRANSPLANTATION, 1995, 15 (02) : 213 - 219
  • [33] Acute and chronic graft-versus-host disease in bone marrow transplantation - Analysis of 167 patients.
    Macedo, MCMA
    Pallotta, RS
    Saboya, R
    Silva, RL
    Jamra, M
    Chamone, DAF
    Dulley, FL
    BLOOD, 1998, 92 (10) : 334B - 334B
  • [34] Unexplained effusions: Association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease
    Seber, A
    Khan, SP
    Kersey, JH
    BONE MARROW TRANSPLANTATION, 1996, 17 (02) : 207 - 211
  • [35] Prophylaxis of acute hepatic graft-versus-host disease with ursodeoxycholic acid in allogeneic bone marrow transplantation
    Iwata, N
    Nakamura, Y
    Masui, H
    Seto, Y
    Takemoto, Y
    Kakishita, E
    HEPATOLOGY, 1997, 26 (04) : 1091 - 1091
  • [36] A metalloproteinase inhibitor prevents acute graft-versus-host disease in mice after bone marrow transplantation
    Hattori, K
    Hirano, T
    Ushiyama, C
    Miyajima, H
    Yamakawa, N
    Ikeda, S
    Yoshino, K
    Tateno, M
    Oshimi, K
    Kayagaki, N
    Yagita, H
    Okumura, K
    BONE MARROW TRANSPLANTATION, 1999, 23 (12) : 1283 - 1289
  • [37] SUCCESSFUL TREATMENT WITH THALIDOMIDE OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION
    LIM, SH
    MCWHANNELL, A
    VORA, AJ
    BOUGHTON, BJ
    LANCET, 1988, 1 (8577): : 117 - 117
  • [38] ABO COMPATIBILITY AND ACUTE GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    BACIGALUPO, A
    VANLINT, MT
    OCCHINI, D
    MARGIOCCO, M
    FERRARI, G
    PITTALUGA, PA
    FRASSONI, F
    PERALVO, J
    LERCARI, G
    CARUBIA, F
    MARMONT, AM
    TRANSPLANTATION, 1988, 45 (06) : 1091 - 1094
  • [39] GRAFT-VERSUS-HOST REACTIONS AND BONE-MARROW TRANSPLANTATION
    BRENNER, MK
    HESLOP, HE
    CURRENT OPINION IN IMMUNOLOGY, 1991, 3 (05) : 752 - 757
  • [40] ACUTE GRAFT-VERSUS-HOST DISEASE IN RECIPIENTS OF SYNGENEIC BONE-MARROW
    BELANGER, R
    TUTSCHKA, PJ
    BESCHORNER, WE
    HESS, AD
    SANTOS, GW
    EXPERIMENTAL HEMATOLOGY, 1982, 10 : 23 - 32